Coverage
-
September 04, 2015
Sanofi-Aventis US LLC has agreed to pay $2.4 million to employees who alleged the pharmaceutical giant shorted them commission payments from sales of the cancer drug Zaltrap, according to a preliminary settlement filed Friday in federal court in New Jersey
1 other articles on this case.
View all »